|
Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
Su-Jin Moon, Hee-Jeoung Yoon, Sung-Ho Her, Jong-Min Lee, Ho-Jung An, Yune-Jeong Lee, Seung-Won Jin
Korean J Intern Med. 2008;23(3):156-160. Published online September 20, 2008
Glycoprotein (GP) IIb/IIIa inhibitors, such as abciximab, are used as adjunctive therapy for percutaneous coronary intervention (PCI) in high-risk non-ST-elevation myocardial infarction (NSTEMI) and in ST-elevation myocardial infarction (STEMI), although their effects when used for STEMI are less..
|
